Fujisawa, Japan

Mitsuyasu Okabe

This inventor holds 3 USPTO granted patents. Top assignee: Sanraku-Ocean Co., Ltd.. Active years: 1984-1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mitsuyasu Okabe. Retrieved from https://idiyas.com/inventor/mitsuyasu-okabe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1984-1985

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mitsuyasu Okabe: Innovator in Antibiotic Development

Introduction

Mitsuyasu Okabe is a notable inventor based in Fujisawa, Japan. He has made significant contributions to the field of antibiotics, holding a total of three patents. His work focuses on the development of novel compounds that enhance antibiotic efficacy.

Latest Patents

One of Okabe's latest patents is for a phosphoric ester of antibiotic OA-6129. This innovative compound is presented by a specific formula wherein R can be a hydrogen atom, hydroxyl, or hydroxysulfonyloxy, along with its salts and preparation method. Another significant patent involves antibiotics and the process for their production, featuring a compound represented by a formula where R can be either a hydrogen atom or a methyl group.

Career Highlights

Mitsuyasu Okabe is associated with Sanraku-ocean Co., Ltd., where he continues to advance his research in antibiotic development. His work has been instrumental in creating new antibiotic formulations that could potentially address various bacterial infections.

Collaborations

Okabe has collaborated with notable colleagues, including Takeo Yoshioka and Yasuo Fukagawa. Their combined expertise has contributed to the successful development of innovative antibiotic solutions.

Conclusion

Mitsuyasu Okabe's contributions to antibiotic research and development highlight his role as a key innovator in the field. His patents reflect a commitment to improving healthcare through advanced pharmaceutical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…